Genome sequencing group Illumina on March 15 launched a cancer test in Europe that checks for a wide range of tumor genes in one tissue sample, potentially helping patients with rare diseases to be matched up with treatment options.
Roche is launching a new genomic profiling kit that lets cancer researchers explore tumors without having to send tissue samples to centralized laboratories, the Swiss drugmaker said on Oct. 25.
South Korea’s Celltrion Inc. received emergency use authorization (EUA) from the U.S. Food and Drug Administration for the rapid Covid-19 testing kit Sampinute, which boosted shares of the company and its affiliates.
In the company’s daily blog about the precautions being taken to ensure continued service to the world, Amazon intends to build testing facilities for employees.
